EP2150249 - Bibliographic data

USE OF BENZO-FUSED HETEROCYCLE SULFAMIDE DERIVATIVES FOR THE TREATMENT OF MIGRAINE

Last update 23/07/2025
Legal status Brevet déchu
Origin Euro-PCT

(73) Holder

JANSSEN PHARMACEUTICA N.V.

Turnhoutseweg 30
2340 Beerse
Belgique
(72) Inventors

SMITH-SWINTOSKY, Virginia L.

3163 Line Lexington Road
Hatfield, PA 19440
États-Unis d'Amérique
(74) Agent

Mail recipient

WARNER, JAMES ALEXANDER ET AL

Carpmaels & Ransford One Southampton Row
London WC1A 2RA
Royaume-Uni

(21) Request number EP07757059.6
(22) Request date 15/02/2007

(11) Publication number EP2150249
Publication date 24/04/2013

(54) Title of the invention USE OF BENZO-FUSED HETEROCYCLE SULFAMIDE DERIVATIVES FOR THE TREATMENT OF MIGRAINE
(51) International classification A61K 31/353A61K 31/357A61K 31/36A61P 25/06
International classification (before reform) None

Claimed priority

(31) Number: 773764 P
(32) Date: 15/02/2006
(33) Country: US


(31) Number: 674021
(32) Date: 12/02/2007
(33) Country: US

Initial application None
Divisional application None

Expected annuity Annuity: 8 - Amount: 105 € - Due date 28/02/2014
Surtax: 8 - Amount: 21 € - Due date 01/09/2014
Last annuity None

Publication

BREVETS D'INVENTION DESIGNANT MC DELIVRES PAR l'OEB - bulletin 2013/2, of 30/06/2013

History

Publication de la délivrance du brevet européen - Legal date 24/04/2013


Entrée en période de grâce du brevet d'invention - Legal date 01/03/2014


Déchéance du brevet d'invention après période de grâce - Legal date 28/02/2014